-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Genenta Science (NASDAQ:GNTA) shares moved upwards by 134.9% to $2.42 during Monday's pre-market session. The market value of their outstanding shares is at $24.1 million.
  • AIM ImmunoTech (AMEX:AIM) stock moved upwards by 23.34% to $0.5. The company's market cap stands at $5.9 million.
  • Hyperliquid Strategies (NASDAQ:PURR) shares moved upwards by 19.81% to $11.97. The market value of their outstanding shares is at $1.4 billion.
  • Geovax Labs (NASDAQ:GOVX) shares moved upwards by 13.61% to $2.34. The company's market cap stands at $10.7 million.
  • Conexeu Sciences (NASDAQ:CNXU) stock increased by 13.0% to $13.25. The company's market cap stands at $245.2 million.
  • GT Biopharma (NASDAQ:GTBP) stock increased by 12.86% to $0.54. The company's market cap stands at $17.2 million.

Losers

  • Oculis Holding (NASDAQ:OCS) shares declined by 30.7% to $15.74 during Monday's pre-market session. The market value of their outstanding shares is at $1.3 billion.
  • Aditxt (NASDAQ:ADTX) stock decreased by 24.75% to $0.09.
  • PRF Technologies (NASDAQ:PRFX) stock decreased by 24.01% to $2.28. The market value of their outstanding shares is at $2.6 million.
  • Clearmind Medicine (NASDAQ:CMND) stock decreased by 22.35% to $2.78. The company's market cap stands at $3.6 million.
  • BiomX (AMEX:PHGE) stock declined by 12.7% to $1.1. The company's market cap stands at $12.7 million.
  • Neogen (NASDAQ:NEOG) shares fell 12.49% to $7.85. The market value of their outstanding shares is at $1.9 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending